share_log
Breakings ·  May 29 19:04
Mediwound Ltd: Escharex(®) Phase III Study to Launch 2H 2024
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment